Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Disease Research, Assay Development Workflows, Metabolic research
        A glimpse into forensic toxicology analysis of opioids: new method development.
            July 24, 2024 -
            1 min read
          
          
         
      Disease Research, Infectious Diseases
        High-content imaging siRNA screens identify trafficking factors in Alphavirus infection.
            July 23, 2024 -
            3 min read
          
          
         
      Automation, Disease Research, NGS
        Automated liquid handling systems: more than pipetting robots.
            July 17, 2024 -
            3 min read
          
          
         
      Drug Development
        Antibody detection provides insights into long-term viral immunity and the efficacy of vaccines.
            July 11, 2024 -
            3 min read
          
          
         
      Small Molecule Drug Discovery
        Discovery solutions with Alpha, HTRF, and multi-mode microplate readers for viral therapeutics.
            July 11, 2024 -
            3 min read
          
          
         
      Small Molecule Drug Discovery
        Optimizing experimental efficiency with multiplex immunoassays.
            July 3, 2024 -
            2 min read
          
          
         
      Precision Medicine, Biomarker Detection
        Maximizing the impact of single-cell sequencing by addressing current bottlenecks.
            July 1, 2024 -
            2 min read
          
          
         
      NGS
        Exploring circulating extracellular vesicles in liquid biopsies for neurological disorders webinar.
            June 26, 2024 -
            1 min read
          
          
         
       
       
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  